Brief: Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval Of Lumryz
30/06/2025 12:19
June 30 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O: AVADEL PHARMACEUTICALS ANNOUNCES UNANIMOUS APPEALS COURT DECISION UPHOLDING FDA APPROVAL OF LUMRYZ IN NARCOLEPSY IN ADMINISTRATIVE PROCEDURE ACT LITIGATION Source text: ID:nGNX8rmWvD Further company coverage: AVDL.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet